75
Participants
Start Date
August 27, 2021
Primary Completion Date
October 18, 2024
Study Completion Date
March 31, 2028
Hancock-Jaffe bioprosthetic venous valve (VenoValve®)
Surgical implantation of the VenoValve device
NYU Langone, New York
Mount Sinai Hospital, New York
Stony Brook Medicine, New York
St. Peter's Vascular Associates, Troy
Albany Medical Center, Albany
Kaleidahealth, Buffalo
UPMC, Pittsburgh
Lankenau Medical Center, Wynnewood
Sentara, Norfolk
University of North Carolina, Chapel Hill
Coastal Vascular, Fort Walton Beach
Miami Vascular Specialists, Miami
University of Alabama at Birmingham, Birmingham
Vanderbilt University Medical Center, Nashville
University of Louisville, Louisville
Jobst Vascular Institute / Promedica Toledo Hospital, Toledo
University Hospitals Cleveland Medical Center, Cleveland
TriHealth, Cincinnati
Indiana University, Indianapolis
Henry Ford Health System, Detroit
University of Chicago, Chicago
Saint Louis University, St Louis
Houston Methodist Hospital, Houston
University of Utah, Salt Lake City
Pima Heart and Vascular, Tucson
Cedars-Sinai Medical Center, Beverly Hills
Yale school of Medicine, New Haven
Massachusetts General Hospital, Boston
Englewood Health, Englewood
Lead Sponsor
Collaborators (1)
AXIOM Real Time Metrics
UNKNOWN
Syntactx
NETWORK
Hancock Jaffe Laboratiores, Inc
NETWORK